Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-08-19

Clinical Trial Results: Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion [Phase 1, Phase 2]

View source ↗

Summary

Phase Ib/2a study evaluating a combination of dextromethorphan with bupropion for addiction/opioid use disorders; results completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextromethorphan (dextromethorphan)
  • bupropion (bupropion)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Addiction, Opioid Use | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-08-19